|
BELPHARMPROM from Belarus seeks Indian collaboration to address demand for essential medicines
|
|
Shardul Nautiyal, Mumbai
April 19 , 2024
|
|
|
In a bid to enhance healthcare provisions in the Republic of Belarus, the Pharmaceuticals Holding Company BELPHARMPROM, under the Ministry of Health, has reached out to Indian pharmaceutical companies for collaboration. This move aims to address the demand for essential medicines and explore opportunities for the localization of finished dosage forms (FDF).
BELPHARMPROM's inquiry, facilitated by the Pharmaceuticals Export Promotion Council of India (Pharmexcil), highlights the growing interest in international partnerships to bolster pharmaceutical supply chains and meet the healthcare needs of nations.
List of the pharmaceutical substances which require assistance in finding its alternative manufacturers and suppliers are potassium orotas, procainamide, promedol, sufentanil citrate, tetrahydrozoline hydrochloride, fentanyl, castor oil, bufexamac and ammonia solution concentrated 25% among others.
Karina Milinkevich, a leading specialist at BELPHARMPROM, expressed the company's interest in procuring specific pharmaceutical substances and facilitating the registration procedure for APIs and medicines in Belarus. The contact details provided signify BELPHARMPROM's openness to direct engagement with potential Indian suppliers.
Uday Bhaskar, director general (DG) of Pharmexcil, welcomed BELPHARMPROM's initiative, emphasizing the potential for fruitful collaboration between Indian pharmaceutical companies and Belarusian authorities. Bhaskar highlighted the significance of such partnerships in promoting global health and ensuring access to quality healthcare products.
Indian pharmaceutical companies, renowned for their expertise in manufacturing high-quality APIs and FDFs, are poised to capitalize on this opportunity. The inquiry presents a platform for Indian firms to expand their market presence and contribute to Belarus's healthcare infrastructure.
As discussions progress, stakeholders anticipate mutually beneficial agreements that will not only address Belarus's healthcare requirements but also foster enduring partnerships between the two nations. The collaboration between BELPHARMPROM and Indian pharmaceutical companies reflects the growing trend of international cooperation in the pharmaceutical sector, underlining the industry's commitment to advancing global health outcomes.
Moving forward, both parties are poised to engage in constructive dialogue and explore avenues for sustainable collaboration, marking a significant milestone in the journey towards accessible and affordable healthcare for all. This initiative underscores the importance of cross-border partnerships in addressing healthcare challenges and underscores the pharmaceutical industry's role as a key driver of global health initiatives.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|